#United States #New York #Natural Cycles #Fertility Algorithm #AI Birth Control

Natural Cycles Achieves Major Milestone with the Sixth FDA Clearance

Natural Cycles, known for creating the first FDA-approved birth control application, has recently announced a significant achievement: the acquisition of its sixth FDA clearance. This milestone introduces their next-generation AI-powered NC° Fertility Algorithm, designed to provide a more personalized birth control experience that adapts to individual menstrual cycle patterns while ensuring established effectiveness rates.

Transforming Digital Contraception

The new algorithm leverages advanced statistical modeling intertwined with machine learning to analyze vast datasets containing tens of millions of data points related to real-world fertility. This innovative approach allows for more individualized fertility predictions, giving many users additional 'Green Days'—days where the app confirms that pregnancy protection is not required.

As emphasized by Dr. Elina Berglund Scherwitzl, CEO and co-founder of Natural Cycles, the aim is not merely about providing effective birth control; it's about offering a solution that seamlessly integrates into users' lives. The unique aspect of a software-based contraceptive is its capacity for evolution over time. Through continuous refinement based on scientific research and validation, Natural Cycles aims to empower users with greater flexibility.

Effectiveness and Safety

Natural Cycles maintains an impressive effectiveness rate of 98% when used as intended and 93% for typical users—placing it in the same effectiveness category as traditional oral contraceptives. The data supporting these figures stem from extensive peer-reviewed clinical research and real-life experiences, showcasing Natural Cycles' dedication to safety and efficacy.

A New Era for Digital Contraception

The digital contraception landscape is rapidly changing. Initially focused on proving that digital methods could effectively work, the focus has now shifted to enhancing the performance and personalization of these solutions. Natural Cycles embraces this shift by enhancing user flexibility. Traditional fertility awareness methods often categorize larger sections of the menstrual cycle as potentially fertile, which could lead to user apprehension. In contrast, Natural Cycles uses sophisticated physiological modeling and machine learning to accurately pinpoint fertile and non-fertile days, thus boosting the number of Green Days without compromising effectiveness.

Dr. Kerry Krauss, a senior medical advisor at Natural Cycles, emphasized the importance of this FDA clearance, noting that it highlights the advancements in AI and machine learning that can enhance user experience while maintaining scientific vigor expected of regulated medical devices.

Key Innovations of the Updated Algorithm

1. Increased Green Days: More days when protection is confirmed as unnecessary.
2. Support for Irregular Cycles: Better performance for individuals with less consistent cycles.
3. Data Handling: Enhanced capability to process lower-quality biomarker and temperature data.
4. Rapid Personalization: Adapts more swiftly to natural changes in users' cycles.

To further bolster its offerings, Natural Cycles has filed a patent application for key innovations present in the latest algorithm, augmenting a robust portfolio developed from years of fertility research.

Sustainability in AI Applications

While the term 'artificial intelligence' has become a trending buzzword in the healthcare space, Natural Cycles has been a pioneer in integrating machine learning into fertility predictions for over ten years. Their technology processes massive amounts of physiological data daily to determine individuals' fertility statuses. The newly FDA cleared algorithm stands as the pinnacle of their fertility modeling technology to date, a testament to years of investment in data science and regulatory compliance.

Looking Ahead

Each FDA clearance acquired by Natural Cycles has expanded either the capabilities or accessibility of regulated digital contraception:

• - 2018: First-ever FDA De Novo clearance for a birth control app.
• - 2021: FDA 510(k) clearance for Oura Ring integration.
• - 2023: FDA 510(k) clearance for Apple Watch integration.
• - 2024: FDA 510(k) clearance with a Predetermined Change Control Plan (PCCP) enabling future hardware integrations.
• - 2025: FDA 510(k) clearance allowing both over-the-counter and prescription offerings.
• - 2026: FDA 510(k) clearance for the next-generation NC° Fertility Algorithm.

Thanks to the PCCP, Natural Cycles can introduce wearable technology, like the NC° Band, along with hardware collaborations, enhancing the experience of users seeking wearable digital contraception.

Natural Cycles boasts regulatory approvals in over eight international markets, including Europe, Canada, Brazil, Australia, South Korea, and Singapore, solidifying its position as a leader in regulated digital contraception.

For more information about Natural Cycles and its innovative approach to reproductive health, visit Natural Cycles.

About Natural Cycles

Founded in 2013 by physicists Dr. Elina Berglund Scherwitzl and Dr. Raoul Scherwitzl, Natural Cycles is a forerunner in women's digital health, dedicated to transforming how women manage and understand their reproductive health. The company has created the first FDA-cleared digital birth control method, housed within an app that utilizes a proprietary algorithm to interpret biomarker data. Serving over six million users globally and backed by extensive research, Natural Cycles continues to champion personalized reproductive health tools and empower women effectively.